关注
Richard J Stopforth
Richard J Stopforth
在 cam.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Therapeutic antibodies: what have we learnt from targeting CD20 and where are we going?
MJE Marshall, RJ Stopforth, MS Cragg
Frontiers in immunology 8, 289045, 2017
1622017
New revelations from an old receptor: Immunoregulatory functions of the inhibitory Fc gamma receptor, FcγRIIB (CD32B)
A Roghanian, RJ Stopforth, LN Dahal, MS Cragg
Journal of leukocyte biology 103 (6), 1077-1088, 2018
362018
Regulation of monoclonal antibody immunotherapy by FcγRIIB
RJ Stopforth, KLS Cleary, MS Cragg
Journal of clinical immunology 36, 88-94, 2016
232016
Shaving is an epiphenomenon of type I and II anti-CD20–mediated phagocytosis, whereas antigenic modulation limits type I monoclonal antibody efficacy
LN Dahal, CY Huang, RJ Stopforth, A Mead, K Chan, JX Bowater, ...
The Journal of Immunology 201 (4), 1211-1221, 2018
222018
HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy
K Hussain, R Liu, RCG Smith, KTJ Müller, M Ghorbani, S Macari, ...
Journal of Experimental & Clinical Cancer Research 41 (1), 131, 2022
112022
The role of antigen presentation in tumor-associated macrophages
RJ Stopforth, ES Ward
Critical Reviews™ in Immunology 40 (3), 2020
112020
Detection of experimental and clinical immune complexes by measuring SHIP-1 recruitment to the inhibitory FcγRIIB
RJ Stopforth, RJ Oldham, AL Tutt, P Duriez, HT Chan, BF Binkowski, ...
The Journal of Immunology 200 (5), 1937-1950, 2018
102018
Therapeutic antibodies: what have we learnt from targeting CD20 and where are we going? Front Immunol. 2017; 8: 1245
MJE Marshall, RJ Stopforth, MS Cragg
32017
The development of a CD32C reporter assay for the study of monoclonal antibody-CD32B interactions
RJ Stopforth, MS Cragg
IMMUNOLOGY 143, 129-130, 2014
2014
系统目前无法执行此操作,请稍后再试。
文章 1–9